Implantica AG (OSTO:IMP A SDB) ROCE % : 0.00% (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is Implantica AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Implantica AG's annualized ROCE % for the quarter that ended in . 20 was 0.00%.

Implantica AG ROCE % Historical Data

The historical data trend for Implantica AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG ROCE % Chart

Implantica AG Annual Data

Trend

ROCE %

Implantica AG Semi-Annual Data

ROCE %

Implantica AG ROCE % Calculation

Implantica AG's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

Implantica AG's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

Implantica AG (OSTO:IMP A SDB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Implantica AG ROCE % Related Terms

Thank you for viewing the detailed overview of Implantica AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

8IM1:Germany

Address

Aeulestrasse 45, Vaduz, LIE, 9490

Website

https://www.implantica.com

Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines